The young have always outnumbered the old, but as fertility rates drop and lifespans go up, this is starting to change.
Category: life extension – Page 675
The biology of aging is traditionally studied in fast-living organisms such as mice, worms and fruit flies. Short-lived species certainly have a role to play in this field, but they are only the tip of the iceberg.
Within the natural ecosystem, organisms display a range of aging processes, most often accelerated aging, or gradual aging (in the case of humans), but also, a range of species with slow or even negligible aging, which is known as negligible senescence. Unlike humans, such species have a constant mortality rate for the duration of their lifespan, as well as a constant or even increasing fertility rate. The number of negligibly senescent species which we are currently aware of is likely to grow as more and more are studied and discovered, both in the wild and in the lab.
By studying the processes which give these creatures longer lifespans, there is the possibility that they could be recreated in humans in order to extend our own. How negligible senescence is achieved by each individual species varies, but here are five of the most common traits.
Interesting article in The Telegraph on biohacking and recent Grindfest, where the Immortality Bus stopped:
Immortality aside, DIY “bio-hacking” could provide solutions to everyday problems, despite the risks involved.
Calorie restriction (CR) is big news in the anti-aging world, but how effective is it really? The evidence might be more mixed than you think.
First major story on Immortality Bus from embedded journalist with Vox:
His campaign’s ’70s RV that’s been rebuilt to look like a giant coffin.
And Can We Use Them To Improve Health and Longevity
Junk DNA may play a critical role in the creation of new DNA.
GDF 11 has been publicised as another fountain of youth molecule, but with contradictory findings, does it live up to the hype, or could it be potentially harmful? It could be a bit of both.
A growing number of tech moguls are trying to solve their biggest problem yet: aging.
From reprogramming DNA to printing organs, some of Silicon Valley’s most successful and wealthy leaders are investing in biomedical research and new technologies with hopes of discovering the secret to living longer.
And their investments are beginning to move the needle, said Zoltan Istvan, a futurist and transhumanist presidential candidate.